Aro Biotherapeutics logo

Aro Biotherapeutics jobs and careers

Philadelphia, PA, United States

About Aro Biotherapeutics

Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.

Founded in 2017 by Karyn O’Neil and Susan Dillon.

Founded
2017
Employees
11 to 50
Total funding
$166.5M
Headquarters
Philadelphia

Leadership

The top of Aro Biotherapeutics's org chart, with how many people report into each leader.

SDPhoto of Susan Dillon

Susan Dillon

Co-Founder, President & CEO

26 reports

KNPhoto of Karyn O’Neil

Karyn O’Neil

CSO

9 reports

ADPhoto of Adam Dinerman

Adam Dinerman

Senior Vice President, Head of CMC

6 reports

ZDPhoto of Zhanna Druzina

Zhanna Druzina

Executive Director

3 reports

MLPhoto of Mark Laurenzi

Mark Laurenzi

Chief Administrative Officer & VP, Legal

1 report

GCPhoto of Glenn C.

Glenn C.

Chief Medical Officer

MB

Melissa Brookes

Vice President Clinical Operations

SSPhoto of Sukumar Sakamuri

Sukumar Sakamuri

Chief Technology Officer

Board

MG

Matthew Gentry

Scientific Advisor

BP

Bruce Peacock

Independent Director

KR

Kevin Raidy

Director

CM

Christopher Mirabelli

Independent Director

MS

Mårten Steen

Director

MMPhoto of Martin McMahon

Martin McMahon

Scientific Advisor